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Assessing the severity of endogenous intoxication 
and defining the nature of digestive system lesion in 
patients with drug-resistant tuberculosis
An important factor for increased incidence of tuberculosis (TB) in different 
countries of the world is the rapid spread of strains of Mycobacterium tuberculosis 
(MBT) resistant to anti-TB drugs 1. In Chernivtsi region, as in the whole country, the 
upward trend in the incidence of multi-resistant tuberculosis is recorded from 4.1 per 
100 thousand of population in 2011 to 5.9 in 2012 (grown by 14.3%, p < 0.05), which 
determines the severity and urgency of the problem of treating such patients.
Treatment of drug-resistant forms of tuberculosis, characterized by the rapid 
multiplication of MBT, massive infiltrative-caseous changes in the lungs, numer-
ous destructions of lung tissue, severe intoxication syndrome, causes considerable 
difficulties.
One of the main reasons for the lack of efficacy of treatment of this group of pa-
tients is adverse side effects that arise during combination therapy of anti-TB drugs. 
1 Наказ МОЗ України від 21.12.2012 № 1091 «Уніфікований клінічний протокол первинної, 
вторинної (спеціалізованої) та третинної медичної допомоги. Туберкульоз».
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They significantly limit the ability of chemotherapy and reduce the effectiveness of 
treatment of pulmonary tuberculosis in basic indicators — the terms of cessation of 
bacterial excretion and frequency of cavities closure 1.
Despite the extensive experience of anti-TB drugs usage, the problem of their side 
effects on a microorganism remains relevant even today. Since the pre-clinical and 
clinical trials can not reveal the whole spectrum of possible adverse side reactions to 
drugs, the need for further research and evaluation of unwanted effects to medication 
and putting them into practice is rather obvious 2.
Recently, numerous research papers in literature have been devoted to the study 
of endogenous intoxication (EI) in various pathological diseases because EI is one of 
the most important criteria that determine the severity of the patient’s condition 3. It is 
proved that EI develops in any pathological condition. Considering the data of many 
researchers, EI — is the poisoning of the body by intermediate and final products of 
metabolism, as a result of their accumulation above normal rate due to either increased 
catabolism or blockade of detoxification systems of the body, with subsequent damage 
of other organs and body systems.
Indirect criterion of the severity of condition of patients with different patho-
logical processes is endogenous intoxication severity. In the specialized literature the 
following components of EI are distinguished: microbiological, biochemical and im-
munological 4. In the development of EI among biochemical processes much atten-
tion is paid to the activation of proteolysis including general enzymatic homeostasis 
of the organism disorders.
There is a key concept of the EI syndrome: the emergence of a systemic inflam-
mation can be caused by a variety of pathological processes such as tissue destruction, 
severe tissue hypoxia and others. It is proved that EI significantly affects the quality of 
life of patients 5. It was evidenced that the EI in various pathological conditions arises in 
the same way. Among the sources of EI the main attention is paid to the foci of inflam-
1 Неблагоприятные воздействия полихимиотерапии при туберкулезе и  некоторые пути 
их устранения [Електронний ресурс]/Инструкция по  применению. Режим доступу: http://
s-laboratory.narod.ru/stud/instr.doc
2 Побочные эффекты противотуберкулезных препаратов [Електронний ресурс]/Режим 
доступу: http://www.sitedf.ru/lechenie/pobochnieEffecti
3 Андрейчин М. А., Бех М. Д., Дем’яненко В. В., Ничик А. З., Ничик Н. А. Методи дослідження 
ендогенної інтоксикації організму (методичні рекомендації). – К., 1998. – 33 с.
4 Дунтау А. П. Механизмы эндотоксикоза при туберкулезе легких/А. П. Дунтау, А. В. Ефремов, 
В. В. Бакаев//Пробл. туберкулеза. – 2000. – № 1. – С. 37–39.
5 Островский В. К. Показатели крови и  лейкоцитарного индекса интоксикации в  оценке 
тяжести и  определении прогноза при воспалительных, гнойных и  гнойно-деструктивных 
заболеваниях/[Островский В. К., Мащенко А. В., Янголенко Д. В., Макаров С. В.].//Клин. лаб. 
диагностика. – 2006. – № 6. – С. 50–53.
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matory destruction, ischemic tissues, and zones of natural vegetation flora in the body. 
The degree of tuberculosis inflammation and the destruction processes are largely 
determined by the intensity of the release of proteolytic enzymes in the affected area 1.
The objective of the scientific work is to determine the degree of activity of 
specific inflammatory process in different clinical forms of drug-resistant TB based on 
complex clinical, laboratory, instrumental and X-ray data, and considering the lack of 
effective treatment of these patients, one of the reasons for which is the mal-absorption 
of drugs in the intestine, to define the prevalence and nature of digestive system lesions, 
depending on the profile of resistance to anti-TB medication; to identify the main side 
effects caused by various anti-TB drugs, which are more common in the region and the 
ways to improve the pharmacological correction of metabolic changes in individual 
units, depending on the functional state of the digestive system.
The results of the research. The object of the study were 112 patients with newly 
diagnosed pulmonary drug-resistant TB and 22 patients with preserved resistance of 
Mycobacterium tuberculosis to anti-TB drugs, who were treated in the hospitals of 
the 1st and 2nd phtisiatric departments of who were treated in hospitals of the 1st and 
2nd divisions Chernovtsy Oblast Tuberculosis Dispensary (OTD) and 20 patients 
with drug-resistant tuberculosis of the Communal City Institution TB Dispensary, 
whose anti-TB drugs intolerance has been studied during the period of 2012–2013. 
The diagnostics of TB and determining the degree of activity of specific inflammatory 
process were applied on the basis of complex clinical, laboratory, radiological and 
bronchological data. For comparison, 21 healthy volunteers were studied by the same 
parameters in the control group.
The results obtained have been processed by the conventional methods using 
Student’s criterion of distinction and applications software package Microsoft Office-
XP, Statistica 6.0 (StatSoft ™) 2.
The group of patients under examination was divided according to their ages as 
follows: young people (20 to 45 years old) accounted for 46.3%, middle-aged indi-
viduals (45 to 59 years old) — 39,02%, senior people (60 to 74) — 7,3%, elderly 
patients (75 to 89) — 7,3%.
The average age of patients was (41,9 ± 1,8). Men predominated — 31 (72.1%).
The patients under examination complained mainly of persistent cough with spu-
tum, fever (37,4–38,9 ºC), periodic shortness of breath, weight loss, general weakness. 
54,9% of the patients were in a satisfactory general condition, 36,1% — in a moderate 
one, and only 9% — in a heavy.
1 Дубинина Е. Е. Окислительная модификация протеинов, ее роль при патологических 
состояниях/Дубинина Е. Е., Пустыгина А. В.//Укр. біохім. журн. – 2008. – № 6. – С. 5–18.
2 Боровиков В. Statistica. Искусство анализа данных на компьютере: Для профессионалов (2-е 
издание). – Москва: Питер, 2003. -688с.
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According to the objective research methods the indicators of heart rate, blood 
pressure and respiratory rate fluctuated within the normal range and subsequent-
ly varied depending on the individual tolerance to chemotherapy. During percus-
sion a clear lung sound prevailed, 20,9% of patients produced a bandbox lung sound 
(which is a sign of compensatory emphysema) and 16.2% — a drum-like tympanic 
sound, because of large cavities. Through auscultatory percussion 83.7% of patients 
demonstrated mostly even weakened vesicular breathing, 16.3% — with bronchial 
component. 72.1% of the surveyed patients had variegated moist crepitant rales over 
the affected areas of the lungs.
In 78,9% of patients, tuberculosis process was characterized by the presence of 
multiple destruction (more than two), massive focal, infiltrative and pneumoscle-
rotic changes in both lungs which go beyond one lobe, complaints of breast pain and 
severe intoxication syndrome (cough, dyspnoea, febrile temperature increase of the 
number of red blood cells and neutrophil granulocytes, and erythrocyte sedimenta-
tion rate).
Allocating by the forms of the disease the largest group of patients with dissemi-
nated pulmonary tuberculosis represented 65.1%. Infiltrative tuberculosis was diag-
nosed among 34.9% of patients.
We analyzed the data on the sensitivity of MBT to anti-TB drugs of the first and 
second line in Chernivtsi region in 112 patients who were treated in the second phthi-
siatric department of the regional anti-tuberculosis dispensary. It was proved that 60 
(53.6%) patients had multi-resistance, including: 9 (8%) — to HR, 22 (19.6%) — to 
HRS, 20 (17.8%) — to HRSE, 3 (2.7%) — to HRE, other 5.4% of patients dem-
onstrate resistance to the following combinations of drugs: HRSEt — 1.8% of pa-
tients, HRSZ, HRSKmEt, HRSKmECm, HRSEEt — 0.9% to each combination. In 
24 (21.4%) patients, MBT mono-resistance was diagnosed: 4 (3.6%) — isoniazid, 
5 (4.5%) — rifampicin, 11 (9.8%) — streptomycin, 1 (0.9%) — to ethambutol, 2 
(1.8%) — to Ethionamidum, 1 (0.9%) — to amikacin. MBT poly-resistance was di-
agnosed in 27 (24.1%) patients. The most common Mycobacterium tuberculosis was 
resistant to a combination of HS (10.7% of patients), much less — to HSE and HEt 
(2.7% each), to SE — 0.4% and to HSEEt — 1.8% of patients to each combination, 
to HE, HSKmEt, HSEt, SEt — 0.9% each. Enhanced resistance of Mycobacterium 
tuberculosis was diagnosed in 0.9% of patients.
The development of adverse side effects during the full chemotherapy course for 
patients with drug-resistant tuberculosis occurs mainly in the first weeks of the inten-
sive phase of treatment. Analysis of the rate of frequency of adverse reactions to anti-
TB drugs was carried out among 132 patients with drug-resistant tuberculosis who 
were treated in the second phthisiatric department of Oblast Tuberculosis Dispensary 
and Communal City Institution TB Dispensary; it amounts for 15.2% of the whole 
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number of patients. In 8% of cases they had to completely withdraw from the further 
use of anti-tuberculosis drugs that cause side effects.
Analyzing the data of clinical, laboratory tests and ultrasound research of the 
abdominal organs by 20 patients with drug-resistant tuberculosis, it appears that 
disruption of the digestive system, mainly by the hepato-pancreato-biliary system in 
the form of diffuse liver changes, sometimes increasing it, as well as signs of chole-
cystopancreatitis occur in patients with mono-resistance — 41%, among patients 
with multi-resistance in 72% of cases, with poly-resistance — almost 90% and all the 
patients with advanced Mycobacterium tuberculosis resistance.
The study of anti-mycobacterial drugs intolerance showed that among the first- 
and second-line anti-tuberculosis medications most common side effects occur when 
taking prothionamide — 30% of patients who complain of nausea, dizziness, abdomi-
nal pain, tachycardia, and application of kanamycin — 25% of patients noticed de-
terioration of hearing and tinnitus. 10% of patients while taking levofloxacin noted 
arthralgia, myalgia, nausea and dizziness. 15% of patients receiving pyrazinamide, eth-
ambutol and gatifloxacin observed allergic reactions such as skin rashes and itch. Other 
15% experienced gastrointestinal disorders — diarrhea, nausea, vomiting while taking 
ofloxacin, coxerin and teriz. With 5% taking closerin an epileptic attack was observed.
We have selected 59  patients with newly diagnosed destructive pulmonary 
tuberculosis, which demonstrated changes in hepato-pancreato-biliary system, 20 of 
which had drug-resistant tuberculosis. They made up the first examination group, the 
2nd group consisted of patients with preserved sensitivity of MBT, and the 3d group 
consisted of 22 patients with pulmonary drug-resistant tuberculosis, who did not reveal 
disorders of the digestive system. Control group consisted of 21 healthy volunteers 
(normal subjects).
Most of the examined patients of groups 2  and 3 (57.5% of cases) revealed 
moderate intoxication syndrome, as evidenced mainly by febrile body temperature, 
complaints of general weakness, fatigue, sudden weight loss, lack of appetite, 
changes in clinical blood: leukocytosis, shift in leukocyte formula, ESR (erythrocyte 
sedimentation rate) acceleration and expressed catarrhal phenomena in the lungs. 
X-raying all patients revealed the destruction of the lungs (1  to 3  lesion areas), 
infiltrative, focal changes of varying prevalence. For a more complete description 
of the severity of the disease, we determined the number of  index  indicators  — 
leukocytic intoxication index (LII), hematological intoxication index (HII), the index 
of leukocytes shift (ILS), lymphocytic index (Ilym) and allergization index (AI). 
Patients with drug-resistant pulmonary tuberculosis with disorders in the hepato-
pancreato-biliary system note an increase in all the index parameters in comparison 
with other groups and an average of 15% higher than indicators of healthy people. 
These patients develop leukocytosis by increasing the relative number of eosinophils 
62 Section 7.
and stab neutrophils, there is a significant decrease in the relative number of peripheral 
blood monocytes.
The reduction of lymphocytic  index  is a direct sign of the presence of 
endotoxemia in groups 1–3 in one way or another. Leukopenia and decrease in ESR 
leads to reduced hematological toxicity index (HTI) and reflects intoxication as a 
stage of endotoxemia. In the examined groups leukocytosis and increased erythrocyte 
sedimentation rate and hence increase of HTI were observed, which indicates that 
there is an intoxication beyond the interstitial space and demonstrates endotoxemia 
on the peripheral blood level. The biggest divergence of LII and HTI was observed in 
group 1, indicating a higher severity of endotoxemia (HTI exceeds LII) (table 1).
Table 1. – Calculation of endogenous intoxication indicators (x ± Sx)
Indicators Group 1(n = 20)
Group 2
(n = 17)
Group 3
(n = 22)
Control group 
practically healthy 
people (n = 21)
Leukocytic intoxication 
index (LII)
1,92±0,07
р<0,05
1,84±0,06
р<0,05
1,89±0,06
р<0,05 1,65±0,03
Hematologic 
toxicity index (HTI)
2,35±0,06
р<0,05
2,03±0,06
р<0,05
2,0±0,06
р<0,05 0,62 ± 0,09
Leukocyte shift index 
(LSI)
3,2±0,07
р<0,01
3,06±0,07
р<0,01
2,9±0,07
р<0,01 1,94±0,05
Lymphocytic index 
(Ilym)
0,35±0,07
р<0,01
0,29±0,07
р<0,01
0,36±0,07
р<0,01 0,57±0,06
Allergization index 
(AI)
0,96±0,06
р<0,01
0,92±0,06
р<0,01
0,89±0,06
р<0,01 0,84±0,04
The probability differences are marked: p — compared with control group, n — 
number of observations.
The analysis of the results of the study also suggests that the severity of 
endogenous  intoxication does not depend on the clinical forms of tuberculous 
processes in the lungs. When comparing the results obtained in the case of infiltrative 
and disseminated forms no possible difference of indicators was observed.
It should also be noted that toxicity indicators are constantly increasing with the 
severity of a form of pulmonary tuberculosis. Leukocytic intoxication index is the most 
sensitive in relation to evaluation of the severity of endogenous intoxication among 
all the examined groups of patients in our research.
All patients had tests for the indicators of ammonia, urea, creatinine in serum. As a 
result, it was found that in all cases the levels of ammonia, urea and creatinine in the serum 
of patients did not exceed the control parameters. The processes that occur during the 
decay of the lung tissue do not lead to significant changes in these indicators. Perhaps 
Medical science 63
the ammonia is neutralized in the liver with sufficient intensity and its level in serum is 
not increased. In the absence of renal disease patients with pulmonary tuberculosis 
do not accumulate ammonia, urea and creatinine in their blood. Namely, the patients 
have adequate metabolic activity of the liver and excretory renal function in these 
cases. The phenomenon of endogenous intoxication in pulmonary tuberculosis is 
not accompanied by the accumulation of low molecular weight products of protein 
catabolism, such as ammonia, urea and creatinine.
Conclusions:
1. Among patients with drug-resistant tuberculosis in Chernivtsi region the most 
frequent is multi-resistance (resistance mainly to combinations of drugs — HRS and 
HRSE), MBT resistance to HS and streptomycin. Therefore, in order to reduce the 
prevalence of drug-resistant TB one should carefully follow the new standards of anti-
mycobacterial therapy and improve medication management in the administrative 
areas, providing supply of medicines and their efficient use.
2. The incidence of adverse reactions to anti-TB drugs is 15.2% of the general 
number of patients. Hepato-pancreato-biliary system disorders occur  in 41% of 
patients with mono-resistance, 72% — with multi-resistance, almost 90% — with poly-
resistance and all patients with advanced resistance of Mycobacterium tuberculosis.
3. In the absence of renal disease patients with pulmonary drug-resistant 
tuberculosis do not accumulate ammonia, urea and creatine in blood. The phenomenon 
of endogenous intoxication is not accompanied by the accumulation of low molecular 
weight products of protein catabolism.
4. Excessively severe acute phase mobilization of body’s defenses is accompanied 
by depletion of detoxification reserves, which may cause TB patients to develop a 
number of negative effects — anemia, hypercoagulability syndrome, malabsorption 
syndrome, etc., which require appropriate adjustment of treatment programmes. 
Transfer of patients to the injection treatment regimen of anti-TB drugs enables a 
100% control of chemotherapy, provides 100% bioavailability of medicine and reduces 
the toxic effect potentiating the primary drug, improves the efficiency and shortens 
the duration of treatment, and also has a pharmacoeconomical effect while treating 
drug-resistant tuberculosis.
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